Condition
Head and Neck Squamous Cell Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Head and Neck Squamous Cell Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (5), United Kingdom (1), South Korea (1)). By phase: Phase 1 (3), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Head and Neck Squamous Cell Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| EPI-326 for EGFR-mutant non-small cell lung cancer and head and neck squamous cell carcinoma | Phase 1 | Los Angeles, California and 7 other locations | Recruiting | Mar 10, 2026 |
| Selective dose reduction of neck radiation in HPV-associated oropharyngeal cancer | Phase 2 | Baltimore, Maryland and 3 other locations | Recruiting | Feb 18, 2026 |
| Injecting a viral particle to treat head and neck cancer | Phase 1 | Stanford, California | Recruiting | Dec 16, 2024 |
| Evaluating a new CAR T-cell therapy for solid tumors expressing EGFR | Phase 1/2 | Gilbert, Arizona and 9 other locations | Recruiting | Nov 12, 2024 |
| Evaluating XB010 for patients with solid tumors | Phase 1 | Irvine, California and 19 other locations | Recruiting | Aug 9, 2024 |
All recruiting trials (5)
-
EPI-326 for EGFR-mutant non-small cell lung cancer and head and neck squamous cell carcinoma
This phase 1 trial will try EPI-326, a new drug, in people with EGFR-mutant non‑small cell lung cancer or advanced head and neck squamous cell carcinoma to find safe doses, study how the body handles it, and look for early signs it shrinks tumors.
-
Selective dose reduction of neck radiation in HPV-associated oropharyngeal cancer
This trial tests whether lowering radiation doses to certain neck lymph nodes or gross disease areas is safe and can reduce side effects for adults with HPV-related oropharyngeal cancer.
-
Injecting a viral particle to treat head and neck cancer
This study is testing a new virus injection to see if it can help treat head and neck cancer in different groups of patients.
-
Evaluating a new CAR T-cell therapy for solid tumors expressing EGFR
This study is testing a new CAR T-cell therapy to see if it can safely help adults with certain solid tumors, like colorectal and lung cancer, that have specific markers.
-
Evaluating XB010 for patients with solid tumors
This study is testing a new drug called XB010, alone and with another medication, to see if it can help people with advanced solid tumors who have few other treatment options.
Related topics
Quick answers
How many Head and Neck Squamous Cell Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), United Kingdom (1 trial), South Korea (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.